Renal denervation for resistant hypertension fails to improve insulin resistance as assessed by hyperinsulinemic-euglycemic step clamp

Diabetes

Volumn 65, Issue 8, 2016, Pages 2164-2168

  Miroslawska, Atena K ^a,b   Gjessing, Petter F ^a,b   Solbu, Marit D ^a,b   Fuskevåg, Ole M ^a   Jenssen, Trond G ^b,c   Steigen, Terje K ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; DISEASE ASSESSMENT; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; GLUCOSE INFUSION; GOLD STANDARD; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; KIDNEY DENERVATION; METABOLIC SYNDROME X; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RESISTANT HYPERTENSION; SIMPLE INDEX ASSESSING INSULIN SENSITIVITY ORAL GLUCOSE TOLERANCE; TREATMENT FAILURE; BLOOD; DENERVATION; DIET RESTRICTION; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HYPERTENSION; INNERVATION; KIDNEY; MALE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLOOD GLUCOSE; BLOOD PRESSURE; C-PEPTIDE; DENERVATION; FASTING; FEMALE; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; KIDNEY; MALE; MIDDLE AGED;

EID: 84980347802     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-0205     Document Type: Article

References (21)

1. Lima NK, Abbasi F, Lamendola C, Reaven GM. Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am J Hypertens 2009;22:106-111
2. Huggett RJ, Scott EM, Gilbey SG, Stoker JB, Mackintosh AF, Mary DA. Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension. Circulation 2003;108:3097-3101
3. Jamerson KA, Julius S, Gudbrandsson T, Andersson O, Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993;21:618-623
4. Lembo G, Capaldo B, Rendina V, et al. Acute noradrenergic activation induces insulin resistance in human skeletal muscle. Am J Physiol 1994;266: E242-E247
5. Julius S, Gudbrandsson T, Jamerson K, Andersson O. The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Press 1992;1:9-19
6. Hering D, Lambert EA, Marusic P, et al. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 2013;61:457-464
7. Mahfoud F, Schlaich M, Kindermann I, et al. Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation 2011;123:1940-1946
8. Miroslawska A, Solbu M, Skjølsvik E, Toft I, Steigen TK. Renal sympathetic denervation: effect on ambulatory blood pressure and blood pressure variability in patients with treatment-resistant hypertension. The ReShape CV-risk study. J Hum Hypertens 2016;30:153-157
9. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005;366: 1059-1062
10. Toft I, Bønaa KH, Eikrem J, Bendiksen AL, Iversen H, Jenssen T. Microalbuminuria in hypertension is not a determinant of insulin resistance. Kidney Int 2002;61:1445-1452
11. Gjessing PF, Fuskevåg OM, Hagve M, Revhaug A, Irtun Ø. Hyperinsulinemic euglycemic step clamping with tracer glucose infusion and labeled glucose infusate for assessment of acute insulin resistance in pigs. Am J Physiol Endocrinol Metab 2010;298:E1305-E1312
12. Finegood DT, Bergman RN, Vranic M. Modeling error and apparent isotope discrimination confound estimation of endogenous glucose production during euglycemic glucose clamps. Diabetes 1988;37:1025-1034
13. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 1959;82:420-430
14. Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care 1994;17:152-154
15. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004;27:1487-1495
16. Bastard JP, Vandernotte JM, Faraj M, et al. Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women. Diabetes Metab 2007;33:261-268
17. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410
18. Natali A, Toschi E, Camastra S, Gastaldelli A, Groop L, Ferrannini E; European Group for the Study of Insulin Resistance (EGIR). Determinants of postabsorptive endogenous glucose output in non-diabetic subjects. Diabetologia 2000;43:1266-1272
19. Muscelli E, Pereira JA, Lazarin MA, da Silva CA, Pareja JC, Saad MJ. Lack of insulin inhibition on insulin secretion in non-diabetic morbidly obese patients. Int J Obes Relat Metab Disord 2001;25:798-804
20. Verloop WL, Spiering W, Vink EE, et al. Denervation of the renal arteries in metabolic syndrome: the DREAMS-study. Hypertension 2015;65: 751-757
21. Schlaich MP, Straznicky N, Grima M, et al. Renal denervation: a potential new treatment modality for polycystic ovary syndrome? J Hypertens 2011;29: 991-996